Psykiatrifonden

Ny national sundhedsprofil understreger behov for flere psykiatriplaner5.3.2026 11:50:41 CET | PsykiatrifondenPressemeddelelse

Danskernes mentale trivsel er under pres. Flere oplever stress, søvnbesvær og mistrivsel. Samtidig er den sociale ulighed i sundhed fortsat tydelig. Det viser Den Nationale Sundhedsprofil, som blev offentliggjort i dag. “Det understreger, hvor central, mental sundhed er på alle politikområder og for hele velfærdssamfundet. Derfor skal vi være indstillet på flere psykiatriplaner og langsigtede investeringer i mange år,” mener Psykiatrifondens direktør Marianne Skjold.
Grünenthal Group

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:55:52 CET | Grünenthal GroupPress release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.
  • 1
  • 2
  • 3
  • 4
  • 5
  • Sidste
  • >>
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye